A Randomized Phase 3 Study of MRTX849 in Combination with Cetuximab versus Chemotherapy in Patients with Advanced Colorectal Cancer with KRAS G12C Mutation with Disease Progression on or After Standard First-Line Therapy

  • Strickland, Andrew (Primary Chief Investigator (PCI))

Project: Research

Project Details

Project Description


StatusNot started

Keywords

  • Randomised clinical trial
  • phase 3 study
  • treatment efficacy
  • treatment safety
  • Colorectal Cancer